Valerio Therapeutics SA Sustainability Reports
Valerio Therapeutics S.A. is a clinical-stage biotechnology company that develops proprietary technology platforms for the targeted delivery of innovative therapies. Its systems include the PlatON, DecoyTAC, and V-Body platforms to advance early-stage compounds toward clinical proof-of-concept.
Sector: Professional & technical services
Country: France
Exchange: Euronext Paris
LEI: 96950018AS30IUG0V528
FIGI: BBG001SN5PR6
14 reports from 2010 to 2025
